Europe's Beating Cancer Plan (EBCP), adopted in February 2021, proposes actions across the four pillars of the cancer pathway, i.e. prevention, early detection, diagnosis and treatment, and quality of life of cancer patients and survivors, and three cross-cutting themes, i.e. research and...

In this annex we include the four case studies conducted for each of the four pillars of the EBCP. Each case study is based on a selection of project grants, procurement contracts and Joint Actions (JA) related to cancer funded under the EU4Health Programme. The case studies cover projects...

The European Commission Initiative on Breast Cancer offers a person-centred quality assurance scheme (the European QA scheme) alongside the European evidence-based guidelines. This initiative aims to support healthcare providers and screening programme organisers, as well as policymakers and...

The European Commission Initiative on Breast Cancer offers a person-centred quality assurance scheme (the European QA scheme) alongside the European evidence-based guidelines. This initiative aims to support healthcare providers and screening programme organisers, as well as policymakers and...

Different types of mathematical models can be used to forecast the development of diseases as well as associated costs and analyse the cost-effectiveness of interventions. The set of models available to assess these parameters, reach from simple independent equations to highly complex...

Background Cancer patients face a costly trade-off between medical care and basic necessities including food. This study aims to explore whether catastrophic health expenditures lead to food insecurity among older cancer survivors in the US. Methods Longitudinal study of individuals aged 50 or...

Objectives To conduct pooled estimates and comparative evaluations of safety and efficacy, alongside cost-effectiveness and value-based pricing analyses, for systemic treatments recommended by the National Comprehensive Cancer Network in refractory colorectal cancer. Methods A comprehensive...

Background Within Finland's breast cancer screening program, all women aged 50-69 are invited to biennial screening. Current European guidelines recommend screening in ages 45-49 and 70-74 conditional upon, inter alia, demonstrated context-specific cost-effectiveness. This study aims to...